74 related articles for article (PubMed ID: 17487450)
1. Chorea as an initial and solitary manifestation of systemic lupus erythematosus with antiphospholipid syndrome in an elderly man.
Javed F; Piranavan P
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38290987
[TBL] [Abstract][Full Text] [Related]
2. A case of immunotherapy-responsive autoimmune hemichorea.
Rodin RE; Venna N; Balaban DT
Ann Clin Transl Neurol; 2024 May; 11(5):1371-1375. PubMed ID: 38644607
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hemichorea in an adolescent with systemic lupus erythematosus and previous ipsilateral cerebral infarction.
Yu YW; Chung CY; Chiou YH; Fang NW
Int J Rheum Dis; 2024 Jan; 27(1):e14886. PubMed ID: 37606173
[TBL] [Abstract][Full Text] [Related]
4. Autonomic neuropathy improving after intravenous immunoglobulin therapy.
Alberti C; Spagliardi J; Barbic F; Doneddu PE; Cutellè C; Furlan R; Nobile-Orazio E
Clin Auton Res; 2024 Apr; 34(2):311-316. PubMed ID: 38733551
[No Abstract] [Full Text] [Related]
5. Autoimmune and Paraneoplastic Chorea: A Review of the Literature.
Kyle K; Bordelon Y; Venna N; Linnoila J
Front Neurol; 2022; 13():829076. PubMed ID: 35370928
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Secondary Chorea: A Review of the Current Literature.
Feinstein E; Walker R
Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():22. PubMed ID: 32775036
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.
Vitaliti G; Tabatabaie O; Matin N; Ledda C; Pavone P; Lubrano R; Serra A; Di Mauro P; Cocuzza S; Falsaperla R
Hum Vaccin Immunother; 2015; 11(12):2749-63. PubMed ID: 26266339
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.
Carecchio M; Cantello R; Comi C
J Immunol Res; 2014; 2014():239398. PubMed ID: 24741580
[TBL] [Abstract][Full Text] [Related]
9. Pragmatic approaches to therapy for systemic lupus erythematosus.
Xiong W; Lahita RG
Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
[TBL] [Abstract][Full Text] [Related]
10. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.
Baizabal-Carvallo JF; Bonnet C; Jankovic J
J Neural Transm (Vienna); 2013 Nov; 120(11):1579-89. PubMed ID: 23580159
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid-related chorea.
Peluso S; Antenora A; De Rosa A; Roca A; Maddaluno G; Brescia Morra V; De Michele G
Front Neurol; 2012; 3():150. PubMed ID: 23097646
[TBL] [Abstract][Full Text] [Related]
12. Hemichorea with antiphospholipid antibodies in a patient with systemic lupus erythematosus.
Brochado AV; Pimenta S; Silva M; Sousa R; Campos MM; Brito I
BMJ Case Rep; 2009; 2009():. PubMed ID: 21853001
[TBL] [Abstract][Full Text] [Related]
13. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
Yildirim-Toruner C; Diamond B
J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
Lazurova I; Macejova Z; Benhatchi K; Oetterová M; Antolová E; Asherson RA; Rovensky J
Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
[TBL] [Abstract][Full Text] [Related]
16. [A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment].
Wakasugi M; Sato T; Maruyama Y; Ueno M; Arakawa M
Ryumachi; 1996 Jun; 36(3):545-50. PubMed ID: 8779791
[TBL] [Abstract][Full Text] [Related]
17. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
[TBL] [Abstract][Full Text] [Related]
18. [Involuntary movement disorders as first manifestation of systemic lupus erythematosus: case report].
Kakehasi AM; Bomtempo CA; Vassalo S; Pimenta RC; Carvalho MA; Cardoso F
Arq Neuropsiquiatr; 2001 Sep; 59(3-A):609-12. PubMed ID: 11588646
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
Sakthiswary R; D'Cruz D
Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
